ramipril,atorvastatin
Pfizer
[]
lost of follow up : 3%. and other remaining questions at #esccongress #secure trial. adherence was improved with #polypill as expected which is key. 
President of CNCF. Member of the ACTION-Group. Associate Editor at Minerva Cardio-Angiology+Archives Med.Science-Scientific Director atAxis TV. tweets on my own